HEALTHJul 14 · 20:55 UTCSTAT NEWSEd Silverman

STAT+: FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded access

The FTC settled a lawsuit with CVS Caremark, alleging it manipulated insulin prices and restricted access, resulting in up to $8.5 billion in patient savings over 10 years. The settlement requires CVS Caremark to change rebate practices and unlock $4.5 billion in pharmacy counter rebates.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Federal Trade CommissionorganizationCVS CaremarkorganizationCVS HealthorganizationCigna’s Express ScriptsorganizationUnitedHealth’s Optum Rxorganizationinsulintopicrebatestopicpharmacy benefit managerstopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJul 10 · 10:00 UTC
Minnesota will share in settlement after CVS doctored its insulin bills
HEALTHJul 8 · 10:44 UTC
$1.8M settlement reached in Atrium Health patient data lawsuit
HEALTHJul 2 · 13:25 UTC
STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more
BUSINESSJul 2 · 23:26 UTC
Atrium Health settles online portal lawsuit for $1.8 million; patients eligible for payouts